home / stock / aavxf / aavxf quote
Last: | $15.15 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $15.15 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$15.15 | $0 | $15.15 | $0 | $0 | 1 | 07-02-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 2,398 | 06-07-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 06-06-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 06-05-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 06-04-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 06-03-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-31-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-30-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-29-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 10,000 | 05-28-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-24-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-23-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-22-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-21-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-20-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-17-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-16-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-15-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-14-2024 |
$15.15 | $0 | $15.15 | $0 | $0 | 5,000 | 05-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“ Abivax ” or the “ Company ”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabi...
PARIS, FRANCE / ACCESSWIRE / February 13, 2024 / Abivax SA (Euronext Paris:ABVX))(NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients...
PARIS, FRANCE / ACCESSWIRE / October 24, 2023 / Abivax SA (Euronext Paris:FR0012333284 - ABVX) (" Abivax " or the " Company "), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in p...